Raghuvir Synthetics Limited has successfully completed the divestment of its subsidiary company, marking the conclusion of a corporate restructuring decision that was initially approved by the Board of Directors on March 27, 2026. The company announced on March 30, 2026, that the transaction involving the complete sale of its shareholding in Dreamsoft Bedsheets Private Limited has been finalized.

Transaction Completion Details

The divestment transaction was completed on March 30, 2026, resulting in Dreamsoft Bedsheets Private Limited ceasing to be a subsidiary of Raghuvir Synthetics Limited. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Buyer Information and Related Party Transaction

The buyers of the shareholding are Mr. Yash Sunil Agarwal and Mr. Hardik Sunil Agarwal, who are promoters of Raghuvir Synthetics Limited. The shares were transferred in equal proportion between the two buyers at Re. 1 per share. This transaction qualifies as a related party transaction conducted on an arms-length basis in compliance with regulatory requirements.

Financial Impact of Divested Subsidiary

Dreamsoft Bedsheets Private Limited had minimal financial contribution to the parent company's operations. The subsidiary's financial performance shows negligible impact on the overall business operations.

Note: As per audited financial statements as on March 31, 2025.

The subsidiary's negative net worth of Rs. 17,10,000 and negligible income contribution indicate that this divestment helps streamline the company's operations and allows management to focus resources on core business activities.

Regulatory Compliance and Documentation

The transaction was conducted in full compliance with SEBI regulations. The company provided comprehensive disclosures in accordance with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The transaction does not fall under any scheme of arrangement, making Regulation 37A of LODR Regulations inapplicable to this divestment. The completion announcement was digitally signed by Sunil Raghubirprasad Agarwal, Chairman & Managing Director, confirming the successful closure of the transaction.

Raghuvir Synthetics Limited's independent directors successfully concluded their statutory review meeting on March 19, 2026, addressing key governance and performance evaluation matters as required under regulatory frameworks.

Meeting Details and Duration

The independent directors' meeting was held on Thursday, March 19, 2026, commencing at 1:30 PM and concluding at 2:00 PM. The focused 30-minute session addressed the company's governance requirements and performance assessment obligations.

Key Areas of Review

The independent directors conducted a comprehensive evaluation across three critical areas during their meeting:

Governance and Information Assessment

The directors specifically assessed the quality, quantity, and timeliness of information flow between the company management and the board. This evaluation ensures that the board can effectively and reasonably perform their duties with adequate and timely information support from the management team.

Regulatory Compliance

The meeting was conducted in compliance with corporate governance requirements, with the outcome formally communicated to BSE Limited. Chairman and Managing Director Sunil Raghubirprasad Agarwal signed the disclosure document, which was digitally authenticated on March 19, 2026, at 14:08:16 +05'30'.

Company Leadership

Sunil Raghubirprasad Agarwal, serving as Chairman and Managing Director with DIN 00265303, oversaw the communication of the meeting outcomes to the stock exchange, ensuring transparency and regulatory compliance in the company's governance processes.